The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 01, 2026

Filed:

Jul. 18, 2025
Applicant:

Moma Therapeutics, Inc., Cambridge, MA (US);

Inventors:

Meredeth A. Mcgowan, Bedford, MA (US);

John R. Butler, Thousand Oaks, CA (US);

Momar Toure, Burlington, MA (US);

Haoxuan Wang, Somerville, MA (US);

Timothy J. Guzi, Sudbury, MA (US);

Yonghong Bai, Lexington, MA (US);

Michael H. Reutershan, Acton, MA (US);

Xin Yan, Newton Highlands, MA (US);

Laurie B. Schenkel, Belmont, MA (US);

Cen Gao, Carmel, IN (US);

Brian Alexander Sosa-Alvarado, Cambridge, MA (US);

Assignee:

MOMA Therapeutics, Inc., Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/16 (2006.01); A61K 31/437 (2006.01); A61K 31/4375 (2006.01); A61K 31/551 (2006.01); C07D 487/16 (2006.01); C07D 498/16 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 471/16 (2013.01); A61K 31/437 (2013.01); A61K 31/4375 (2013.01); A61K 31/551 (2013.01); C07D 487/16 (2013.01); C07D 498/16 (2013.01); C07D 519/00 (2013.01);
Abstract

The present disclosure relates to compounds of Formula (I′): and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for modulating Werner Helicase (WRN) activity and may be used in the treatment of disorders in which WRN activity is implicated, such as cancer.


Find Patent Forward Citations

Loading…